IRIS
SCHWARTZ, PETER
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.899
EU - Europa 9.385
AS - Asia 7.363
SA - Sud America 75
AF - Africa 41
OC - Oceania 21
Continente sconosciuto - Info sul continente non disponibili 18
Totale 29.802
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.764
CN - Cina 6.665
IE - Irlanda 2.589
UA - Ucraina 2.005
DE - Germania 1.414
FI - Finlandia 1.053
SE - Svezia 869
IT - Italia 711
SG - Singapore 592
GB - Regno Unito 411
FR - Francia 147
CA - Canada 129
BR - Brasile 65
RU - Federazione Russa 64
BE - Belgio 45
IN - India 33
NL - Olanda 32
MU - Mauritius 31
JP - Giappone 27
EU - Europa 17
IR - Iran 17
AU - Australia 15
ES - Italia 14
AT - Austria 9
NZ - Nuova Zelanda 6
IQ - Iraq 5
MX - Messico 5
CL - Cile 4
HK - Hong Kong 4
HU - Ungheria 4
MA - Marocco 4
MY - Malesia 3
RO - Romania 3
AR - Argentina 2
CH - Svizzera 2
CZ - Repubblica Ceca 2
DK - Danimarca 2
GR - Grecia 2
KE - Kenya 2
KW - Kuwait 2
NO - Norvegia 2
SA - Arabia Saudita 2
TR - Turchia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AZ - Azerbaigian 1
BD - Bangladesh 1
BY - Bielorussia 1
CO - Colombia 1
EG - Egitto 1
ET - Etiopia 1
ID - Indonesia 1
IL - Israele 1
JO - Giordania 1
KG - Kirghizistan 1
KR - Corea 1
LT - Lituania 1
LU - Lussemburgo 1
LV - Lettonia 1
PA - Panama 1
PE - Perù 1
PK - Pakistan 1
PT - Portogallo 1
PY - Paraguay 1
TN - Tunisia 1
VE - Venezuela 1
VN - Vietnam 1
ZA - Sudafrica 1
Totale 29.802
Salva come PNG Salva come JPEG
Città #
Chandler 2.644
Jacksonville 2.587
Dublin 2.585
Nanjing 2.097
Boardman 889
Ashburn 862
Nanchang 851
Princeton 640
Lawrence 603
Shenyang 593
Hebei 571
Wilmington 559
Changsha 558
Jiaxing 510
Medford 408
Singapore 390
Helsinki 342
Tianjin 324
Hangzhou 310
Beijing 288
Munich 234
Ann Arbor 195
Woodbridge 148
Milan 141
Verona 115
Shanghai 113
Norwalk 112
Toronto 62
Fairfield 61
Houston 54
Kunming 54
Seattle 54
New York 53
Pavia 53
Mcallen 52
Des Moines 47
Los Angeles 46
Washington 45
Falls Church 42
Montréal 37
Zhengzhou 36
Brussels 35
Ningbo 35
Jinan 33
Tokyo 26
Nuremberg 25
Dearborn 23
Fuzhou 22
Rome 21
Guangzhou 20
Lanzhou 19
Pune 19
Orange 18
San Genesio Ed Uniti 17
Tappahannock 17
Chicago 16
Taizhou 16
Changchun 15
Falkenstein 15
Berlin 14
Auburn Hills 13
Bari 13
Borås 13
Pescara 11
Chieti 10
Dallas 9
Redwood City 8
Rochester 8
San Francisco 8
St Petersburg 8
Catanzaro 7
Madrid 7
Florence 6
Frankfurt am Main 6
Liverpool 6
Mountain View 6
Antwerp 5
Hefei 5
London 5
Melbourne 5
Monmouth Junction 5
Moscow 5
Napoli 5
Padova 5
Palermo 5
Saint Petersburg 5
Saint-herblain 5
Sydney 5
São Paulo 5
Tübingen 5
Walnut 5
Zola Predosa 5
Bastia umbra 4
Jinhua 4
Kansas City 4
Kingston 4
Legnaro 4
Leuven 4
Mexico City 4
Ottawa 4
Totale 21.022
Salva come PNG Salva come JPEG
Nome #
Vagus nerve stimulation: from pre-clinical to clinical application: challenges and future directions. 222
Identificazione di microRNA circolanti specificatamente sovra espressi in corso di infarto miocardico acuto. 218
Calcio antagonisti e aritmie da riperfusione miocardica 161
[A new experimental model for the study of arrhythmias dependent on the interaction between myocardial ischemia and sympathetic hyperactivity. I. Effects of phosphocreatinine]. 151
[Changes of a reflex nature in the cardiac sympathetic activity induced with increases of arterial pressure in spinal animals]. 135
[Legal implications of medical guidelines. A Task Force of the European Society of Cardiology]. 122
[Idiopathic syndrome of the long QT interval--the need for a prospective study]. 117
Common variants at SCN5A-SCN10A and HEY2 are associated with Brugada syndrome, a rare disease with high risk of sudden cardiac death. 104
PREDESTINATION: PRimary vEntricular fibrillation and suDden dEath during a firST myocardIal iNfArcTION: Genetic basis. 96
The LQT2 KCNH2-Q376Q splicing muation: functional characterization, molecular correction and therapeutic implication. 89
A KCNH2 branch point mutation causing aberrant splicing contributes to an explanation of genotype-negative long QT syndrome. 88
[Activity of preganglionic sympathetic single fibers during experimental coronary occlusion]. 87
[Study of preganglionic sympathetic single fibers in relation to various physiologic and pathologic stimuli]. 87
Aspetti elettrofisiologici della modulazione dei canali del potassio ATP-dipendenti 87
[Activity of afferent cardiac vagal fibers during experimental myocardial ischemia]. 85
[Sympathetic reflex induced by experimental coronary occlusion]. 84
Spectrum and prevalence of mutations involving BrS1-12 susceptibility genes in a cohort of unrelated patients referred for Brugada Syndrome genetic testing: implications for genetic testing. 84
Identification of a KCNQ1 polymorphism acting as a protective modifier against arrhythmic risk in long-QT syndrome. 83
Genetic testing in the long QT syndrome: development and validation of an efficient approach to genotyping in clinical practice 82
FGF12 is a candidate Brugada syndrome locus. 82
Mortalità infantile e morte improvvisa in culla in Lombardia 80
Risk stratification in the Long-QT Syndrome 78
Alpha 1-adrenergic blockade and sudden cardiac death. 77
Multiscale complexity analysis of the cardiac control identifies asymptomatic and symptomatic patients in long QT syndrome type 1. 77
Individual autonomic profile contributes to the risk for life-threatening arrhythmias among KCNQ1-A341V mutation carriers 76
The ICD for the long QT syndrome: which indications, complications, and results? 76
Electrocardiographic and genetic screening for long QT syndrome: results from a prospective study on 44,596 neonates. 76
Novel human pathological mutations. Gene symbol: SCN5A. Disease: Brugada Syndrome. 76
Antifibrillatory efficacy of ersentilide, a novel beta-adrenergic and Ikr blocker, in conscious dogs with a healed myocardial infarction. 76
Linee Guida. Task Force sulla Morte Cardiaca Improvvisa, Società Europea di Cardiologia. Riassunto delle raccomandazioni 76
Role of common and rare variants in SCN10A: results from the Brugada syndrome QRS locus gene discovery collaborative study 75
Cardiac arrhythmias of genetic origin are important contributors to Sudden Infant Death Syndrome. 73
Scopolamine increases vagal tone and vagal reflexes in patients after myocardial infarction 73
Legal implications of medical guidelines. A task Force of the European Society of Cardiology 72
Autonomic mechanisms and sudden death. New insights from analysis of baroreceptor reflexes in conscious dogs with and without a myocardial infarction. 72
A common polymorphism associated with antibiotic-induced cardiac arrhythmia 72
Ranolazine in the treatment of atrial fibrillation: Results of the dose-ranging RAFFAELLO (ranolazine in atrial fibrillation following an electrical cardioversion) study 72
Autonomic nervous system and sudden cardiac death. Experimental basis and clinical observations for post-myocardial infarction risk stratification. 71
Rapid heart rate increase at onset of exercise predicts adverse cardiac events in patients with coronary artery disease 71
QT prolongation and sudden infant death syndrome - from theory to evidence. 71
Long QT and short QT syndromes. 71
Farmaci antipsicotici, QT lungo, morte improvvisa e rischio cardiovascolare. Il cardiologo incontra lo psichiatra 71
All LQT3 patients need an ICD. True or false? 70
QT prolongation, sudden death, and sympathetic imbalance: the pendulum swings. 70
Cardiac sodium channel dysfunction in sudden infant death syndrome. 70
Sertraline treatment of major depression in patients with acute MI or unstable angina. 70
A sympathetic reflex elicited by experimental coronary occlusion. 69
K+ channel blockade in the prevention of ventricular fibrillation in dogs with acute ischemia and enhanced sympathetic activity. 68
[Infant mortality and sudden crib death in Lombardy]. 68
THE SUDDEN INFANT DEATH SYNDROME: CARDIO-RESPIRATORY MECHANISMS AND INTERVENTIONS. 68
Congenital long QT and short QT syndromes 68
Cost-effectiveness of Neonatal ECG as a Screening for Long QT-syndrome: A Decision Analysis Approach. 67
QT lungo, sindrome del 67
Phenotypic variability and unusual clinical severity of congenital long-QT syndrome in a founder population. 67
A common polymorphism associated with antibiotic-induced cardiac arrhythmia. 67
Adrenergic Arrhythmogenesis and The Long QT syndrome 67
A novel rare variant in SCN1Bb linked to Brugada syndrome and SIDS by combined modulation of Na(v)1.5 and K(v)4.3 channel currents. 67
Task Force Report: The legal implications of medical guidelines - a Task Force of the European Society of Cardiology 66
Cost effectiveness of neonatal ECG screening for the long QT syndrome: reply. 66
Acute oral drug testing in the evaluation of a new antiarrhythmic agent: Penticainide (CM 7857) 66
The long QT syndrome. Prospective longitudinal study of 328 families. 66
25th anniversary of the International Long-QT Syndrome Registry: an ongoing quest to uncover the secrets of long-QT syndrome. 66
Sympathetic activation, ventricular repolarization and Ikr blockade: implications for the antifibrillatory efficacy of potassium channel blocking agents 66
Nuovi rischi medico-legali per il cardiologo: la cardiologia molecolare ed il caso della sindrome del QT lungo. 65
Inherited cardiac arrhythmia syndrome. Role of potassium channels 65
[Prevention of sudden death in myocardial infarct: do experimental results help to understand the clinical reality? The case of the clinical trial SWORD (Survival With ORal D-sotalol)]. 65
An experimental approach to the choice of antiarrhythmic therapy. 65
Can a message from the dead save lives? 65
Cardiac potassium channel dysfunction in sudden infant death syndrome. 65
Scopolamine increases vagal tone and vagal reflexes in patients after myocardial infarction. 65
Prevalence of the congenital long-QT syndrome. 65
on Behalf of the Azimilide Trials Investigators: Cumulative experience of azimilide-associated torsades de pointes ventricular tachycardia in the 19 clinical studies comprising the azimilide database 64
Multiple mechanisms of Na+ channel--linked long-QT syndrome. 64
Spectrum of ST-T-wave patterns and repolarization parameters in congenital long-QT syndrome: ECG findings identify genotypes 63
Gene symbol: SCN5A 63
Arrhythmogenic disorders of genetic origin. Long QT Syndrome: from genetics to management. 63
Silent myocardial ischemia in diabetic and nondiabetic patients with coronary artery disease. 63
A Molecular Link between the Sudden Infant Death Syndrome and the Long-QT Syndrome. 63
Significance of Qt dispersion in the long QT syndrome 62
Significant left ventricular reverse remodelling following radiofrequency ablation of monomorphic ventricular ectopy in pts with idiopathic cardiomyopathy 62
Two cases of sudden unexpected death in epilepsy in a GEFS+ family with an SCN1A mutation. 62
Cardiac arrhythmias elicited by interaction between acute myocardial ischemia and sympathetic hyperactivity: a new experimental model for the study of antiarrhythmic drugs. 62
Progress in the evaluation of a new class I antiarrhythmic agent: Penticainide 62
Protective effect of vagal stimulation on reperfusion arrhythmias in cats. 62
Long QT syndrome-associated mutations in intrauterine fetal death. 62
The quest for the mechanism of the sudden infant death syndrome. Doubts and progress 61
Update of the guidelines on sudden cardiac death of the European Society of Cardiology 61
The RecordAF Study: design, baseline data, and profile of patients according to chosen treatment strategy for atrial fibrillation 61
Mortality in the Survival With ORal D-sotalol (SWORD) trial: why did patients die? 61
The long QT syndrome: a clinical counterpart of hERG mutations. 61
[Cardio-cardiac sympathico-vagal reflex]. 61
Chronic vagus nerve stimulation (CVNS) – A new target for treatment of congestive heart failure. 61
Lack of correlation between occlusion and reperfusion arrhythmias in the cat. 60
Autonomic mechanisms in ventricular fibrillation induced by myocardial ischemia during exercise in dogs with healed myocardial infarction. An experimental preparation for sudden cardiac death. 60
Multiple comparison of several antiarrhythmic agents by acute oral drug testing in patients with chronic ventricular arrhythmias 60
Unilateral stellectomy and dysrhythmias. 60
New mutations in the KVLQT1 potassium channel that cause long QT Syndrome. 60
Cardiac arrhythmias in infancy: prevalence, significance and need for treatment. 60
Vagal stimulation for heart failure 60
Torsade de pointes 60
Totale 7.619
Salva come PNG Salva come JPEG
Categoria #
all - tutte 127.501
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 127.501
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.346 0 0 0 0 0 0 28 451 13 553 262 39
2020/20213.657 437 345 108 376 36 486 11 569 117 560 503 109
2021/20222.401 31 10 72 28 34 176 30 129 173 67 390 1.261
2022/20237.639 921 455 58 608 836 888 6 456 3.103 34 170 104
2023/20242.416 259 528 108 197 280 647 52 128 7 67 69 74
2024/20252.052 120 683 194 251 110 284 410 0 0 0 0 0
Totale 30.086